Comparison of Gadobenate Dimeglumine and Gadopentetate Dimeglumine: A Study of MR Imaging and Inductively Coupled Plasma Atomic Emission Spectroscopy in Rat Brain Tumors
Tian Zhanga,
Akira Matsumuraa,
Tetsuya Yamamotoa,
Fumiyo Yoshidaa,
Tadao Nosea and
Nobuhiro Shimojob
a Department of Neurosurgery, Institute of Clinical Medicine, University of Tsukuba, Ibaraki, Japan
b Department of Environmental Medicine, Institute of Community Medicine, University of Tsukuba, Ibaraki, Japan

View larger version (69K):
[in a new window]
|
FIG 1. Serial T1-weighted spin-echo MR images (514/28) obtained before and at 5 minutes, 30 minutes, 1 hour, and 2 hours after contrast agent administration.
AE, Gd-BOPTA was the contrast agent used.
FJ, Gd-DTPA was the contrast agent used.
| |

View larger version (19K):
[in a new window]
|
FIG 2. L/B time profiles after IV administration of 0.1 mmol/kg of Gd-BOPTA and Gd-DTPA during T1-weighted imaging (514/28) at 2.4 T. Data are mean ± SD of six animals.
| |

View larger version (29K):
[in a new window]
|
FIG 3. Graphic representation of the gadolinium concentration in brain tissue in rats that received Gd-BOPTA. (Gd indicates gadolinium; BT, brain tumor; PT, peritumoral tissue; NB, normal brain.)
| |

View larger version (29K):
[in a new window]
|
FIG 4. Graphic representation of gadolinium concentration in brain tissue in rats that received Gd-DTPA.
| |

View larger version (29K):
[in a new window]
|
FIG 5. Graphic comparison of BT/NB with Gd-BOPTA versus that of Gd-DTPA.
| |